Sp1052
ESOPHAGEAL EPITHELIUM AND MECHANISMS OF REMODELING
Date
May 9, 2023
Explore related products in the following collection:
Society: AGA
This session will feature speakers who will examine the mechanisms of inflammation and epithelial tissue remodeling during eosinophilic esophagitis (EoE). Epithelial cell and immune cell biology will be discussed. Biologics currently used for targeted therapeutic interventions in EoE will be considered.
This session will feature speakers who will examine the mechanisms of inflammation and epithelial tissue remodeling during eosinophilic esophagitis (EoE). Epithelial cell and immune cell biology will be discussed. Biologics currently used for targeted therapeutic interventions in EoE will be considered.
Presenter
Temple University Lewis Katz School of Medicine
Tracks
Related Products
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
INTRODUCTION
SOCIETY: AGA
BASAL ZONE HYPEPLASIA IS DRIVEN BY SUPERBASAL CELLS THAT RETAIN STEM CELL IDENTITY PROGRAMS IN ADULT EOE
Background: Eosinophilic Esophagitis (EoE) is one of the most predominant causes of chronic esophageal symptoms in children. Pathological changes of the esophageal epithelium in EoE are characterized by basal cell hyperplasia (BCH), infiltration of eosinophils and elevated levels of cytokines (e.g…
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
